Pulmonary arterial hypertension (PAH) in primary Sjögren‘s syndrome: report of 9 cases Source: Eur Respir J 2007; 30: Suppl. 51, 344s Year: 2007
Are we screening survivors of acute pulmonary embolism (PE) for chronic thromboembolic pulmonary hypertension (CTEPH)? Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011
Impact of inherited activated protein C resistance on pulmonary artery pressure after acute episode of pulmonary thromboembolism Source: Eur Respir J 2001; 18: Suppl. 33, 380s Year: 2001
Chronic thromboembolic pulmonary hypertension: update 2004 Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=243 Year: 2004
Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene Source: Eur Respir J 2001; 17: 1065-1069 Year: 2001
Pulmonary embolism and the consequences for the right heart Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=136 Year: 2006
A 1-year evolution of pulmonary artery pressure in the patients treated with various therapeutic methods after acute pulmonary embolism (PE). Its impact on the chronic thromboembolic pulmonary hypertension (CTEPH) development Source: Eur Respir J 2003; 22: Suppl. 45, 221s Year: 2003
Prevalence of relapses and chronic thromboembolic pulmonary hypertension (CTEPH) in patients with pulmonary embolism (PE) Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016
Contribution of thrombophilic genetic factors in development and recurrent manifestation of pulmonary embolism in young patients Source: Annual Congress 2005 - News about pulmonary embolism Year: 2005
Correspondence regarding “T-box protein 4 mutation causing pulmonary arterial hypertension and lung disease”: a single-centre case series Source: Eur Respir J, 55 (5) 1902272; 10.1183/13993003.02272-2019 Year: 2020
Chronic thromboembolic pulmonary hypertension (CTEPH) and coagulation defects: Before and after treatment Source: International Congress 2017 – PAH and CTEPH Year: 2017
Chronic thromboembolic pulmonary hypertension in acute pulmonary embolism: A risk factor evaluation study Source: Virtual Congress 2020 – Pulmonary embolism Year: 2020
Haemoptysis revealing a thrombosis of an arterial aneurysm secondary to inherited protein C deficiency Source: Eur Respir J 2006; 28: Suppl. 50, 42s Year: 2006
Pulmonary hypertension (PH) associated with neurofibramatosis (NFM): a case series Source: Eur Respir J 2007; 30: Suppl. 51, 349s Year: 2007
Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2) Source: Eur Respir J 2015; 45: 1293-1302 Year: 2015
Chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: to screen or not to screen? Source: Eur Respir J, 51 (4) 1800440; 10.1183/13993003.00440-2018 Year: 2018
Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature Source: Eur Respir J , 49 (2) 1601792; DOI: 10.1183/13993003.01792-2016 Year: 2017
Mismatch of major vessel obstruction and pulmonary vascular resistance (PVR) in chronic thromboembolic pulmonary hypertension (CTEPH) with associated medical conditions (AMC) Source: Eur Respir J 2006; 28: Suppl. 50, 402s Year: 2006
Presence of inherited risk factors in patients with pulmonary thromboembolism (PTE) Source: Eur Respir J 2005; 26: Suppl. 49, 521s Year: 2005
Predicting recurrent pulmonary embolism and chronic thromboembolic pulmonary hypertension: one more way to skin the cat Source: Eur Respir J, 49 (5) 1700413; 10.1183/13993003.00413-2017 Year: 2017